Skip to main content

Advertisement

SpringerLink
Log in

Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

In a proportion of patients, chikungunya arthritis (CA) might run into a chronic persistent phase. The treatment for this phase is not very clear. In this randomized parallel group open label study of 24 weeks duration, we evaluated the efficacy of DMARD combination in persistent CA. Consecutive 139 patients with persistent CA (persistent arthritis for >1 year after the chikungunya fever either in 2008 or 2009 fulfilling epidemiological criteria for CA) were screened. Of these patients who were already taking hydroxychloroquine (HCQ) and had active arthritis were randomized to receive either fixed-dose combination therapy (methotrexate 15 mg/day, sulfasalazine 1 g/day, and HCQ 400 mg/day) or continue with HCQ 400 mg/day (dose optimized) monotherapy. Both groups received oral prednisolone up to 6 weeks. Assessments at every 4 weeks were carried out for primary efficacy (disease activity score; DAS ESR 28) and secondary efficacies, HAQ—Indian version and pain VAS100mm. Seventy-two patients were randomized (37 combination therapy, 35 monotherapy). Both groups were well matched in all respects. At 24 weeks, the combination therapy group showed significant improvement in both disease activity (mean ± SD DAS28; 3.39 ± 0.87 vs. 4.74 ± 0.65, p < 0.0001) and disability (mean ± SD HAQ; 1.4 ± 0.31 vs. 1.88 ± 0.47, p < 0.0001). At the study end, pain VAS was significantly less in the combination therapy group (46 ± 6.13 vs. 60.8 ± 11.6, p < 0.0001). Three patients withdrew from the combination group (inefficacy; 2, adverse event; 1) and seven from monotherapy (inefficacy; 7). This study provide evidence that for chronic persistent CA combination DMARD therapy with methotrexate, sulfasalazine and HCQ is superior to monotherapy with HCQ.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Mathew AJ, Ravindran V (2014) Infections and arthritis. Best Pract Res Clin Rheumatol 28:935–959

    Article  PubMed  Google Scholar 

  2. Kularatne SA, Weerasinghe SC, Gihan C, Wickramasinghe S, Dharmarathne S, Abeyrathna A et al (2012) Epidemiology, clinical manifestations, and long-term outcomes of a major outbreak of chikungunya in a hamlet in Sri Lanka, in 2007: a longitudinal cohort study. J Trop Med 2012:1–7

    Article  Google Scholar 

  3. Chopra A, Anuradha V, Lagoo-Joshi V, Kunjir V, Salvi S, Saluja M (2008) Chikungunya virus aches and pains: an emerging challenge. Arthritis Rheum 58:2921–2922

    Article  PubMed  Google Scholar 

  4. Adizie T, Adebajo AO (2014) Travel- and immigration-related problems in rheumatology. Best Pract Res Clin Rheumatol 28:973–985

    Article  CAS  PubMed  Google Scholar 

  5. Kuek A, Hazleman BL, Gatson JH, Oostor AJK (2006) Chikungunya outbreak—remember the arthropathy. Rheumatology 45:1449–1450

    Article  Google Scholar 

  6. Staples JE, Breiman RF, Powers AM (2009) Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin Infect Dis 49:942–948

    Article  PubMed  Google Scholar 

  7. Ryman KD, Klimstra WB (2014) Closing the gap between viral and noninfectious arthritis. Proc Natl Acad Sci U S A 111:5767–5768

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Brighton SW, Prozesky OW, de la Harpe AL (1983) Chikungunya virus infection. A retrospective study of 107 cases. S Afr Med J 63:313–315

    CAS  PubMed  Google Scholar 

  9. Manimunda SP, Vijayachari P, Uppoor R, Sugunan AP, Singh SS, Rai SK et al (2010) Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. Trans R Soc Trop Med Hyg 104:392–399

    Article  PubMed  Google Scholar 

  10. Chopra A, Saluja M, Venugopalan A (2014) Effectiveness of chloroquine and inflammatory cytokine response in patients with early persistent musculoskeletal pain and arthritis following chikungunya virus infection. Arthritis Rheumatol 66:319–326

    Article  CAS  PubMed  Google Scholar 

  11. Chaaithanya IK, Muruganandam N, Raghuraj U, Sugunan AP, Rajesh R, Anwesh M et al (2014) Chronic inflammatory arthritis with persisting bony erosions in patients following chikungunya infection. Indian J Med Res 140:142–145

    PubMed  PubMed Central  Google Scholar 

  12. World Health Organization, Regional Office for South-East Asia. Proposed case definition of Chikungunya fever. Available at http://www.searo.who.int/entity/emerging_diseases/topics/Def_Chikungunya_Fever.pdf.

  13. Choy EH, Smith CM, Farewell V, Walker D, Hassell A, Chau L, Scott DL (2008) CARDERA (combination anti-rheumatic drugs in early rheumatoid arhritis) trial group. Factorial randomized controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis. Ann Rheum Dis 67:656–663

    Article  CAS  PubMed  Google Scholar 

  14. Prevoo ML, van’t Hof MA, Kuper HH et al (1995) Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38:44–48

    Article  CAS  PubMed  Google Scholar 

  15. van Gestel AM, Prevoo ML, van ‘t Hof MA, van Rijswijk MH, van de Putte LB, van Riel PL (1996) Development and validation of the European league against rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 39:34–40

    Article  PubMed  Google Scholar 

  16. Kumar A, Malaviya AN, Pandhi A, Singh R (2002) Validation of an Indian version of the health assessment questionnaire in patients with rheumatoid arthritis. Rheumatology (Oxford) 41:1457–1459

    Article  CAS  Google Scholar 

  17. Bosi Ferraz M, Quaresma MC, Aquino LRL et al (1990) Reliability of pain scales in the assessment of literate and illiterate patients in rheumatoid arthritis. J Rheumatol 17:1022–1024

    Google Scholar 

  18. Aletaha D, Neogi T, Silman AJ et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/ European League against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580–1588

    Article  PubMed  Google Scholar 

  19. Chopra A, Anuradha V, Ghorpade R, Saluja M (2012) Acute chikungunya and persistent musculoskeletal pain following the 2006 Indian epidemic: a 2 year prospective rural community study. Epidemiol Infect 140:842–850

    Article  CAS  PubMed  Google Scholar 

  20. Borgherini G, Poubeau P, Staikowsky F et al (2007) Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients. Clin Infect Dis 44:1401–1407

    Article  PubMed  Google Scholar 

  21. Bouquillard E, Combe B (2009) Rheumatoid arthritis after chikungunya fever: a prospective follow-up study of 21 cases. Ann Rheum Dis 68:1505–1506

    Article  CAS  PubMed  Google Scholar 

  22. Suhrbier A, Jaffar-Bandjee MC, Gasque P (2012) Arthritogenic alphaviruses—an overview. Nat Rev Rheumaol 8:420–429

    Article  CAS  Google Scholar 

  23. Sudeep AB, Parashar D (2008) Chikungunya: an overview. J Biosci 33:443–449

    Article  CAS  PubMed  Google Scholar 

  24. Scott DL, Ibrahim F, Farewell V, O’Keeffe AG, Walker D, Kelly C, Kingsley GH (2015) Tumour necrosis factor inhibitors versus combination intensive therapy with conventional disease modifying anti-rheumatic drugs in established rheumatoid arthritis: TACIT non-inferiority randomised controlled trial. The. BMJ 350:h1046. doi:10.1136/bmj.h1046

    Article  PubMed  PubMed Central  Google Scholar 

  25. Gaujoux-Viala C, Nam J, Ramiro S, Landewé R, Buch MH, Smolen JS, Gossec L (2014) Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis. Ann Rheum Dis 73:510–515

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Pandya S (2008) Methotrexate and hydroxychloroquine combination therapy in chronic chikungunya arthritis: a 16 week study. Indian J Rheumatol 3:93–97

    Article  Google Scholar 

  27. Suhrbier A, La Linn M (2004) Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses. Curr Opin Rheumatol 16:374–379

    Article  PubMed  Google Scholar 

  28. Chaaitanya IK, Muruganandam N, Sundaram SG, Kawalekar O, Sugunan AP, Manimunda SP et al (2011) Role of pro-inflammatory cytokines and chemokines in chronic arthropathy in CHIKV infection. Viral Immunol 24:265–271

    Article  CAS  PubMed  Google Scholar 

  29. Tang BL (2012) The cell biology of chikungunya virus infection. Cell Microbiol 14:1354–1363

    Article  CAS  PubMed  Google Scholar 

  30. Brighton SW (1984) Chloroquine phosphate treatment of chronic chikungunya arthritis: an open pilot study. S Afr Med J 66:217–218

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology, PVS Hospital, Calicut, India

    Vinod Ravindran & George Alias

  2. Centre for Rheumatology, Calicut, Kerala, 673009, India

    Vinod Ravindran

Authors
  1. Vinod Ravindran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. George Alias
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Vinod Ravindran.

Ethics declarations

Ethical approval

Necessary approvals were obtained from the ethics committee of our institution. Informed written consent was obtained from all patients prior to their enrolment in this study.

Disclosures

None.

Funding

None.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ravindran, V., Alias, G. Efficacy of combination DMARD therapy vs. hydroxychloroquine monotherapy in chronic persistent chikungunya arthritis: a 24-week randomized controlled open label study. Clin Rheumatol 36, 1335–1340 (2017). https://doi.org/10.1007/s10067-016-3429-0

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-016-3429-0

Keywords

Search

Navigation